Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

SELL
$8.12 - $10.63 $193,475 - $253,281
-23,827 Reduced 6.17%
362,069 $3.78 Million
Q3 2023

Oct 31, 2023

BUY
$7.48 - $10.7 $2.86 Million - $4.09 Million
382,559 Added 11464.16%
385,896 $3.94 Million
Q2 2023

Jul 31, 2023

BUY
$7.2 - $9.47 $24,026 - $31,601
3,337 New
3,337 $25,000
Q2 2020

Aug 17, 2020

SELL
$8.12 - $13.12 $828,272 - $1.34 Million
-102,004 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$6.69 - $13.45 $682,406 - $1.37 Million
102,004 New
102,004 $916,000
Q4 2018

Feb 11, 2019

SELL
$14.59 - $23.84 $1.86 Million - $3.03 Million
-127,176 Closed
0 $0
Q3 2018

Nov 08, 2018

SELL
$21.06 - $25.65 $5.25 Million - $6.4 Million
-249,451 Reduced 66.23%
127,176 $2.74 Million
Q2 2018

Aug 03, 2018

SELL
$16.77 - $24.71 $2.08 Million - $3.06 Million
-123,881 Reduced 24.75%
376,627 $9.16 Million
Q1 2018

May 14, 2018

SELL
$16.68 - $22.07 $6.19 Million - $8.19 Million
-371,099 Reduced 42.58%
500,508 $8.55 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $3.92 Million - $6.66 Million
348,762 Added 66.7%
871,607 $16.5 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $2.21 Million - $4.62 Million
143,497 Added 37.83%
522,845 $9.2 Million
Q2 2017

Aug 08, 2017

BUY
N/A
379,348
379,348 $12.6 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Tobam Portfolio

Follow Tobam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.